For example, SNPs in HMGCR (the target for statins) show only a modest (but highly significant) effect on CHD risk, but the role of statins in the prevention of CHD is well established. 37 , 38 The fact that tocilizumab has been shown to be safe in large trials in humans adds further weight to the translational potential of the present findings.
1
—
—